<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral sinus and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> account for less than 1% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0001297'>strokes</z:hpo>, but diagnosis is often overlooked due to the variety of clinical syndromes and the variable clinical course </plain></SENT>
<SENT sid="1" pm="."><plain>Underlying conditions do not significantly differ from those seen in extracerebral <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Conventional intra-arterial four-vessel angiography was long the only diagnostic technique for confirming diagnosis, but nowadays magnetic resonance imaging and angiography are sufficient in many cases </plain></SENT>
<SENT sid="3" pm="."><plain>Full-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment is the therapy of choice and is performed even if an hemorrhagic <z:mpath ids='MPATH_124'>infarct</z:mpath> already exists </plain></SENT>
<SENT sid="4" pm="."><plain>If treatment is initiated early, the mortality rate of nonseptic cerebral sinus and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> is less than 10% </plain></SENT>
<SENT sid="5" pm="."><plain>According to general rules of postthrombotic treatment, patients should be treated with oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> for a period of at least three months </plain></SENT>
</text></document>